Have a personal or library account? Click to login
Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis Cover

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis

Romanian Journal of Internal Medicine
Volume 59 (2021): Issue 3 (September 2021)
By: Denisa-Corina Ciuculete,  Raluca Alexandra Popescu and  Gheorghe-Andrei Dan  
Open Access
|Aug 2021
DOI: https://doi.org/10.2478/rjim-2021-0015 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 270 - 277
Submitted on: Mar 13, 2021
Published on: Aug 26, 2021
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
ibrutinib,
atrial fibrillation,
anticoagulation,
thromboembolic prophylaxis,
haemorrhagic risk
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2021 Denisa-Corina Ciuculete, Raluca Alexandra Popescu, Gheorghe-Andrei Dan, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 59 (2021): Issue 3 (September 2021)